379 related articles for article (PubMed ID: 31738849)
1. Successful treatment of hidradenitis suppurativa in the setting of Crohn disease with combination adalimumab and ustekinumab.
Cline A; Pichardo RO
Dermatol Online J; 2019 Sep; 25(9):. PubMed ID: 31738849
[TBL] [Abstract][Full Text] [Related]
2. Adalimumab treatment for hidradenitis suppurativa associated with Crohn's disease.
Diamantova D; Lomickova I; Cetkovska P
Acta Dermatovenerol Croat; 2014; 22(4):291-3. PubMed ID: 25580790
[TBL] [Abstract][Full Text] [Related]
3. Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox?
Martina E; Campanati A; Giuliodori K; Offidani A
Acta Dermatovenerol Alp Pannonica Adriat; 2017 Mar; 26(1):21-23. PubMed ID: 28352932
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience of the use of adalimumab in the management of hidradenitis suppurativa. Comparison of response rates with Crohn disease.
Moyano B; Clemente A; Marín-Jiménez I; Martorell A
Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():43-50. PubMed ID: 28081769
[TBL] [Abstract][Full Text] [Related]
5. High-dose, high-frequency ustekinumab therapy for patients with severe hidradenitis suppurativa.
Jiang SW; Kwock JT; Liu B; Petty AJ; Zhao AT; Green CL; Jaleel T
Br J Dermatol; 2022 Sep; 187(3):417-419. PubMed ID: 35192196
[TBL] [Abstract][Full Text] [Related]
6. Observational case series on adalimumab-induced paradoxical hidradenitis suppurativa.
Delobeau M; Abdou A; Puzenat E; Deveza E; Biver-Dalle C; van de Laak A; Roche-Kubler B; Vuitton L; Koch S; Wendling D; Aubin F
J Dermatolog Treat; 2016; 27(3):251-3. PubMed ID: 26368546
[TBL] [Abstract][Full Text] [Related]
7. Hidradenitis suppurativa and Crohn's disease: two cases that support an association.
Yazdanyar S; Miller IM; Jemec GB
Acta Dermatovenerol Alp Pannonica Adriat; 2010 Oct; 19(3):23-5. PubMed ID: 20976417
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of co-existent SAPHO syndrome and hidradenitis suppurativa with adalimumab and methotrexate.
Genovese G; Caorsi R; Moltrasio C; Marzano AV
J Eur Acad Dermatol Venereol; 2019 Oct; 33 Suppl 6():40-41. PubMed ID: 31535768
[TBL] [Abstract][Full Text] [Related]
9. Overview and update on biologic therapy for moderate-to-severe hidradenitis suppurativa.
Porter ML; Golbari NM; Lockwood SJ; Kimball AB
Semin Cutan Med Surg; 2018 Sep; 37(3):182-189. PubMed ID: 30215636
[TBL] [Abstract][Full Text] [Related]
10. Ustekinumab treatment for hidradenitis suppurativa.
Takeda K; Kikuchi K; Kanazawa Y; Yamasaki K; Aiba S
J Dermatol; 2019 Dec; 46(12):1215-1218. PubMed ID: 31638283
[TBL] [Abstract][Full Text] [Related]
11. Hidradenitis suppurativa and perianal Crohn disease: differential diagnosis.
Bassas-Vila J; González Lama Y
Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():27-31. PubMed ID: 28081767
[TBL] [Abstract][Full Text] [Related]
12. Ustekinumab for hidradenitis suppurativa: a case report.
Santos-Pérez MI; García-Rodicio S; Del Olmo-Revuelto MA; Pozo-Román T
Actas Dermosifiliogr; 2014 Sep; 105(7):720-2. PubMed ID: 24308927
[No Abstract] [Full Text] [Related]
13. Longitudinal observational study of hidradenitis suppurativa: impact of surgical intervention with adjunctive biologic therapy.
Shanmugam VK; Mulani S; McNish S; Harris S; Buescher T; Amdur R
Int J Dermatol; 2018 Jan; 57(1):62-69. PubMed ID: 29130482
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
Rosi YL; Lowe L; Kang S
J Dermatolog Treat; 2005 Feb; 16(1):58-61. PubMed ID: 15897171
[TBL] [Abstract][Full Text] [Related]
15. Combination hyperbaric oxygen therapy and ustekinumab for severe hidradenitis suppurativa.
Provini LE; Stellar JJ; Stetzer MN; Nguyen PD; Jen M
Pediatr Dermatol; 2019 May; 36(3):381-383. PubMed ID: 30805965
[TBL] [Abstract][Full Text] [Related]
16. Concomitant psoriasis and hidradenitis suppurativa responsive to adalimumab therapy: A case series.
Yen CF; Huang YH; Chi CC
Indian J Dermatol Venereol Leprol; 2021; 87(2):223-226. PubMed ID: 31389375
[TBL] [Abstract][Full Text] [Related]
17. Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patient.
Katsanos KH; Christodoulou DK; Tsianos EV
Am J Gastroenterol; 2002 Aug; 97(8):2155-6. PubMed ID: 12190206
[No Abstract] [Full Text] [Related]
18. Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis. Comment on 'Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab'.
Martora F; Fabbrocini G; Marasca C; Battista T; Megna M
Clin Exp Dermatol; 2023 Jun; 48(6):701-703. PubMed ID: 36883596
[No Abstract] [Full Text] [Related]
19. SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate: a case report and review of the literature.
Vekic DA; Woods J; Lin P; Cains GD
Int J Dermatol; 2018 Jan; 57(1):10-18. PubMed ID: 28884797
[TBL] [Abstract][Full Text] [Related]
20. HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study.
Kimball AB; Sobell JM; Zouboulis CC; Gu Y; Williams DA; Sundaram M; Teixeira HD; Jemec GB
J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):989-94. PubMed ID: 26201313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]